Korean biotech firm bought by Parataxis for Bitcoin treasury use
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Original source
Read on CointelegraphRelated market context
South Korea finance ministry says tokenized stocks are securities, not crypto assets, opening door to taxes: report
South Korea’s finance ministry said tokenized stocks are securities, opening potential taxation as early as H2 2026 if regulators...
Solana News: SpaceX Will Have the Biggest IPO in History, And Its Stock Will Be Trading on Solana the Same Day
Solana News: On June 12, 2026, the same day SpaceX will be trading on Nasdaq at $135/share, raising $75 billion in the largest IPO...
Bitcoin Trader Says Retail Will Return After A Sudden 20% BTC Candle
TL;DR X trader Cup says Bitcoin may be in a quiet accumulation phase before a larger move. The post claims retail traders could re...
Kraken Prepares CFTC-Regulated Perpetual Futures Launch For US Traders
TL;DR Kraken says it plans to launch CFTC-regulated perpetual futures for eligible US traders within 30 days. Contracts will be li...
Metaplanet to Launch Bitcoin Yield Products in Japan After $13 Million Siiibo Securities Deal
Metaplanet has agreed to acquire Siiibo Securities, a licensed Japanese Type I securities firm, as part of its Project Nova strate...
Bitcoin price faces new risk as big buyers lose conviction
Bitcoin’s largest buyers are no longer behaving like a reliable backstop for the largest cryptocurrency. The exchange-traded funds...